FDA label 62e2535a-e8b0-4a24-9b3c-5ebc09da79c0
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)
- SPL set ID
- 5811335c-a579-4b93-94cd-5cdacd97a324
- SPL ID
- 62e2535a-e8b0-4a24-9b3c-5ebc09da79c0
- Version
- 9
- Effective date
- 2019-01-24
- Source export date
- 2026-09-28
- Source partition
- 13
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0013-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-09-28/e78bf8aa9f90ab13e640d254dfbd4fe5bfeca4995ec5f9d51bce3356e249cab7/drug-label-0013-of-0014.json.zip
- Source manifest SHA-256
- cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
- Import run
- 20260929T050834Z
- Imported at
- 2026-09-29 06:34:36
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
Harmonized identifiers page 1 of 1 · 2 matching rows.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Adverse reactions sections page 1 of 1 · 2 matching rows.
adverse reactions
ADVERSE REACTIONS The following local adverse reactions have been reported with corticosteroid suppositories: • Burning • Itching • Irritation • Dryness • Folliculitis • Hypopigmentation • Allergic Contact Dermatitis • Secondary Infection
adverse reactions table
<table width="75%"> <col width="35%"/> <col width="40%"/> <tbody> <tr> <td styleCode="Botrule Toprule " valign="top"> <list listType="unordered"> <item> <caption>•</caption>Burning</item> <item> <caption>•</caption>Itching</item> <item> <caption>•</caption>Irritation</item> <item> <caption>•</caption>Dryness</item> </list> </td> <td styleCode="Botrule Toprule " valign="top"> <list listType="unordered"> <item> <caption>•</caption>Folliculitis</item> <item> <caption>•</caption>Hypopigmentation</item> <item> <caption>•</caption>Allergic Contact Dermatitis</item> <item> <caption>•</caption>Secondary Infection</item> </list> </td> </tr> </tbody> </table>
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.